Early changes in cardiac troponin T and NT-proBNP levels in neonates receiving ECMO support: a single-center experience.

[1]  J. Lei,et al.  The accuracy and influencing factors of Doppler echocardiography in estimating pulmonary artery systolic pressure: comparison with right heart catheterization: a retrospective cross-sectional study , 2021, BMC Medical Imaging.

[2]  Y. Singh,et al.  Pathophysiology and Management of Persistent Pulmonary Hypertension of the Newborn. , 2021, Clinics in perinatology.

[3]  K. T. Wild,et al.  Extracorporeal Life Support Organization (ELSO): Guidelines for Neonatal Respiratory Failure. , 2020, ASAIO journal.

[4]  H. Hillege,et al.  Serial Measurements of N-Terminal Pro-B-Type Natriuretic Peptide Serum Level for Monitoring Pulmonary Arterial Hypertension in Children. , 2020, The Journal of pediatrics.

[5]  P. Levy,et al.  Comprehensive Evaluation of Right Heart Performance and Pulmonary Hemodynamics in Neonatal Pulmonary Hypertension , 2019, Current Treatment Options in Cardiovascular Medicine.

[6]  C. Sinning,et al.  Definition, clinical classification and initial diagnosis of pulmonary hypertension: Updated recommendations from the Cologne Consensus Conference 2018. , 2018, International journal of cardiology.

[7]  H. Yip,et al.  Associations with the In-Hospital Survival Following Extracorporeal Membrane Oxygenation in Adult Acute Fulminant Myocarditis , 2018, Journal of clinical medicine.

[8]  M. Chi,et al.  [A review on neonatal acute respiratory distress syndrome]. , 2018, Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics.

[9]  C. Ravishankar,et al.  Elevated Troponin in the First 72 h of Hospitalization for Pediatric Viral Myocarditis is Associated with ECMO: An Analysis of the PHIS+ Database , 2018, Pediatric Cardiology.

[10]  K. Oba,et al.  Vasoactive-inotropic score as a predictor of morbidity and mortality in adults after cardiac surgery with cardiopulmonary bypass , 2018, Journal of Anesthesia.

[11]  Christopher L. Jenks,et al.  Pediatric Extracorporeal Membrane Oxygenation. , 2017, Critical care clinics.

[12]  G. Zhu,et al.  Myocardial protection of early extracorporeal membrane oxygenation (ECMO) support for acute myocardial infarction with cardiogenic shock in pigs , 2015, Heart and Vessels.

[13]  Balaji Krishnan,et al.  Orthostatic hypotension of unknown cause: Unanticipated association with elevated circulating N-terminal brain natriuretic peptide (NT-proBNP). , 2015, Heart rhythm.

[14]  Chiadi E. Ndumele,et al.  The association of liver enzymes with biomarkers of subclinical myocardial damage and structural heart disease. , 2015, Journal of hepatology.

[15]  S. Karam,et al.  Cardiac Troponin Levels in Neonates Who Require ECMO for Noncardiac Indications Are Elevated in Nonsurvivors , 2015, American Journal of Perinatology.

[16]  M. Gianni,et al.  How to predict short- and long-term mortality in patients with pulmonary embolism? , 2015, Polskie Archiwum Medycyny Wewnetrznej.

[17]  D. Dursunoglu,et al.  Evaluation of cardiac biomarkers and right ventricular dysfunction in patients with acute pulmonary embolism , 2014, Anatolian journal of cardiology.

[18]  C. Puelacher,et al.  High-sensitivity cardiac troponin in acute conditions , 2014, Current opinion in critical care.

[19]  Y. Dohi,et al.  Kidney function crucially affects B‐type natriuretic peptide (BNP), N‐terminal proBNP and their relationship , 2014, European journal of clinical investigation.

[20]  P. Becker,et al.  Survival of Newborn Infants With Severe Respiratory Failure Before and After Establishing an Extracorporeal Membrane Oxygenation Program* , 2013, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[21]  R. Bartlett,et al.  Current status of extracorporeal life support (ECMO) for cardiopulmonary failure. , 2010, Minerva anestesiologica.

[22]  J. Heinle,et al.  Serial Plasma BNP Levels in Assessing Inadequate Left Ventricular Decompression on ECMO , 2008, Pediatric Cardiology.

[23]  D. Tibboel,et al.  N-Terminal-pro-B Type Natriuretic Peptide as a Useful Tool to Evaluate Pulmonary Hypertension and Cardiac Function in CDH Infants , 2007, Neonatology.

[24]  H. Bada,et al.  Brain-Type Natriuretic Peptide in the Diagnosis and Management of Persistent Pulmonary Hypertension of the Newborn , 2004, Pediatrics.

[25]  D. Wilkerson,et al.  Pediatric extracorporeal membrane oxygenation. , 1992, Critical care nurse.

[26]  S. Kuribayashi,et al.  Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension. , 1998, Journal of the American College of Cardiology.